Latest Breaking News On - Syndicate prospectus department - Page 3 : comparemela.com

American Superconductor (AMSC) Prices 5 4M Share Offering at $11 25/sh

American Superconductor (AMSC) Prices 5 4M Share Offering at $11 25/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkRoth capital partnersSyndicate prospectus departmentCraig hallum capital groupAmerican superconductor corporation nasdaqOppenheimer coExchange commissionAmerican superconductor corporationHallum capital group

AMSC Announces Proposed Public Offering of Common Stock

AMSC Announces Proposed Public Offering of Common Stock

United statesNew yorkCarolyn capaccioNicol golezOppenheimer coSenior communicationsAmerican superconductor corporation nasdaqSyndicate prospectus departmentExchange commissionSecurities exchangeAmerican superconductor corporationBetter energyProposed public offeringSuperconductor corporationAmerican superconductorSecurities exchange act

Corbus Pharmaceuticals Announces Proposed Public Offering

NORWOOD, Mass., Jan. 30, 2024 Corbus Pharmaceuticals Holdings, Inc. , a precision oncology company with a diversified portfolio, today announced that it plans to offer and sell shares of its.

New yorkUnited statesBruce mackleSean moranEquity syndicate prospectus departmentCorbus pharmaceuticals contactsExchange commissionCorbus pharmaceuticals holdings incGlobenewswire incLifesci advisorsCorbus pharmaceuticalsPharmaceuticals holdingsSyndicate prospectus departmentPrivate securities litigation reform actAnnual reportQuarterly reports

Renewable Energy Stock - AMSC (Nasdaq: AMSC) Prices Upsized $60 Million Public Offering of Common Stock

Renewable Energy Stock - AMSC (Nasdaq: AMSC) Prices Upsized $60 Million Public Offering of Common Stock

United statesNew yorkCarolyn capaccioNicol golezExchange commissionAmerican superconductor corporationOppenheimer coSenior communicationsCraig hallum capital groupBetter energyLike renewable energy stocksSecurities exchangeSyndicate prospectus departmentRoth capital partnersNewswire american superconductor corporation nasdaqHallum capital group

Adicet Bio, Inc Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters Option to Purchase Additional Shares

BOSTON - Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the closing.

United statesNew yorkWedbush pacgrowAnne bowdidgeAdicet bio incEquity syndicate departmentExchange commissionEquity syndicate prospectus departmentGuggenheim securitiesCitizens companySyndicate prospectus departmentSyndicate departmentNews publishing